Scandion Oncology A/S Annual Report 2019 published
Scandion Oncology A/S (“Scandion Oncology”) hereby publishes the Annual Report for 2019. The Annual Report 2019 is available on the company's website (www.scandiononcology.com).For further information regarding Scandion Oncology, please contact: Nils Brünner, CEO Phone: +45 26 14 47 08 E-mail: nb@scandiononcology.com Scandion Oncology A/S is a biotechnology company that addresses one of the greatest challenges in modern oncology – the effective treatment of cancer which contains chemotherapy-resistant cells or which has developed resistance to a previously prescribed cancer-